Approvals/CIMA-AEMPS/DAPTOMICINA HIKMA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG

Approved

STANDARD

DAPTOMICINA HIKMA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG

Hikma Farmaceutica (Portugal) S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: a9f6ecf78af1fa1e
Drug Cima Aemps Name: DAPTOMICINA HIKMA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG
Register Number: 89474
Holder Company Name: Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name: Hikma España, S.L.U.
Holder Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a
Authorization Date: 2024-06-04
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Dose: 350 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Hikma Farmaceutica (Portugal) S.A.
Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a

DAPTOMICINA

350 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 4, 2024

Approval ID

a9f6ecf78af1fa1e

Type

Standard